The firm said Jan. 18 that the system consists of a triangulation platform and an instrument for tissue piercing and approximation that can be affixed to an array of different endoscopes. The system enables suturing similar to what a laparoscopic approach allows, while using only natural orifices for an incisionless procedure.
Endo Tools Therapeutics said it’s planning a limited U.S. market release in the first half of 2022, with a wider release later in the year.
